Verum.de to provide clinical research services for oncology center in Romania
Verum.de, a Germany-based full-clinical service CRO, has entered into an agreement with the Center for Oncologic Diagnosis and Treatment (Oncocard) in Romania to be its preferred provider of clinical trial services.
The center, developed with the first private investment funding in oncology in Romania, is brand new and features state-of-the-art services and equipment. The center selected Verum.de as their CRO of choice so they could assist with running clinical trials and offer patients all possible treatment options.
"The esteemed medical professionals involved with the center provide patients a sophisticated level of treatment and services that are rare for the area," said Verum's local Romanian medical director Laurentiu Nedelcu, a doctor and pharmacologist who has supervised Verum trials since 1996. "Verum is known for its regional expertise, and we're pleased to be the CRO the center has chosen to work with."
The center, which opened in June, 2012, is a 86,112 square foot clinic offering full spectrum oncologic chemotherapy, radiotherapy, treatment of hematological malignancies and surgical services to patients in addition to serving as an investigative center for research. The center's medical staff is highly qualified and many of the staff doctors have experience working with Verum. To date, more than 1,700 patients have been treated at the facility and more than 3,800 investigations have been performed.
"The center was opened to offer a higher level of care to cancer patients, with the best services and equipment modern medicine has available," explained the center's medical director, Dr. Mihai Ciochinaru. "We trust working with a CRO such as Verum, which runs trials in an efficient, highly ethical manner and understands the region."
Verum provides clinical trial services with Western standards in Central and Eastern European countries (CEE) and former Soviet bloc countries. Verum recently opened a U.S. office in Carlsbad to assist U.S. clients with international trials.